4,305 Shares in Cabot Co. (NYSE:CBT) Acquired by Freestone Grove Partners LP

Freestone Grove Partners LP bought a new position in Cabot Co. (NYSE:CBT - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 4,305 shares of the specialty chemicals company's stock, valued at approximately $393,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in CBT. Barclays PLC lifted its stake in Cabot by 103.9% in the third quarter. Barclays PLC now owns 113,614 shares of the specialty chemicals company's stock worth $12,699,000 after acquiring an additional 57,907 shares during the period. Franklin Resources Inc. purchased a new stake in shares of Cabot in the 3rd quarter worth approximately $654,000. Delta Financial Group Inc. bought a new position in shares of Cabot during the fourth quarter valued at approximately $274,000. JPMorgan Chase & Co. increased its holdings in Cabot by 27.1% during the fourth quarter. JPMorgan Chase & Co. now owns 451,513 shares of the specialty chemicals company's stock valued at $41,228,000 after buying an additional 96,179 shares during the period. Finally, Empowered Funds LLC bought a new position in Cabot in the fourth quarter worth approximately $1,269,000. Institutional investors own 93.18% of the company's stock.

Wall Street Analyst Weigh In

CBT has been the topic of several recent research reports. Mizuho dropped their target price on Cabot from $122.00 to $110.00 and set an "outperform" rating on the stock in a research report on Tuesday, January 7th. JPMorgan Chase & Co. dropped their price objective on Cabot from $105.00 to $85.00 and set an "underweight" rating on the stock in a research report on Friday, February 21st. StockNews.com upgraded shares of Cabot from a "hold" rating to a "buy" rating in a report on Thursday, April 17th. Finally, UBS Group decreased their price target on shares of Cabot from $93.00 to $83.00 and set a "neutral" rating for the company in a research report on Monday, April 7th.

Cabot Stock Up 0.9 %

Cabot stock opened at $77.89 on Monday. Cabot Co. has a 1-year low of $73.63 and a 1-year high of $117.46. The business has a fifty day moving average price of $81.15 and a 200-day moving average price of $92.32. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.00 and a quick ratio of 1.29. The stock has a market capitalization of $4.22 billion, a price-to-earnings ratio of 10.34, a PEG ratio of 0.74 and a beta of 0.91.

Cabot (NYSE:CBT - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Equities research analysts forecast that Cabot Co. will post 7.57 EPS for the current fiscal year.

Cabot Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.